Elsevier and the International Partnership for Antimicrobial Chemotherapy published an article on the effects of the antimalarial drug hydroxychloroquine in COVID-19 International Journal of Antimicrobial Agents. The authors were scientists from the Mediterranean Infectious Diseases Research Center of the IHU near Marseille, under the supervision of Philippe Gautret, the author of which was the director of the installation, Didier Raoult. The publication, cited 3,859 times, became the basis for emergency recommendations for the infection, through which millions of patients were being treated for unnecessary drugs with unsafe side effects, writes Science.
They have paid attention to the inconsistency of the article even in the few days since its publication on January 20, 2020. The sample included only 36 patients, and the review process took several days. In addition, the results included six patients who were taking off hydroxychloroquine, one of whom died and three were transferred to the intensive care unit, and the limit values of the PLR test were The main and control groups were different. Further testing did not confirm the effectiveness of the drug; the drug began to gain popularity. This had a great resonance among the scientific and medical community, and before this was established, the directors issued a court summons.